(Q35569906)

8 August 2017

1 reference

title

Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61677-8

26 March 2024

author name string

H. William Kelly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582810

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582810

26 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1081120610616778?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61677-8

https://api.elsevier.com/content/article/PII:S1081120610616778?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61677-8

Annals of Allergy, Asthma & Immunology

26 March 2024

published in

1 reference

8 August 2017

volume

91

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

326-34; quiz 334-5, 404

1 reference

Clinical considerations in the use of inhaled corticosteroids for asthma

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Comparison of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Anti-inflammatory properties of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Transcriptional potencies of inhaled glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Asthma stability after oral prednisone: a clinical model for comparing inhaled steroid potency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Time to onset of effect of fluticasone propionate in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Systemic effect comparisons of six inhaled corticosteroid preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: a 14-day dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Safety of inhaled and intranasal corticosteroids: lessons for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Biological esterification of steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Pulmonary targeting of liposomal triamcinolone acetonide phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961677-8

7 January 2021

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

series ordinal

31

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61677-8

Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes

26 March 2024

series ordinal

50

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61677-8

26 March 2024

Identifiers

1 reference

8 August 2017

1 reference